MeiraGTx Holdings (MGTX) Deferred Taxes (2017 - 2018)
MeiraGTx Holdings' (MGTX) quarterly Deferred Taxes came in at -$12.4 million in Q4 2018, down 430.95% YoY from $3.8 million in Q4 2017, and down 92970.79% on a QoQ basis from -$13365.0 in Q3 2018.
Powered by 
Analysis
MeiraGTx Holdings (MGTX) Deferred Taxes (2017 - 2018) Analysis & Trends
MeiraGTx Holdings (MGTX) has 2 years of Deferred Taxes data on file, last reported at -$12.4 million in Q4 2018.
- Quarterly Deferred Taxes fell 430.95% year-over-year to -$12.4 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$12.5 million (changed N/A YoY) and the FY2019 annual result came in at -$9.8 million, up 21.96% from the prior year.
- Deferred Taxes fell to -$12.4 million in Q4 2018, from -$13365.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $3.8 million in Q4 2017 to a low of -$12.4 million in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -12.44 Mn |
| Sep 30, 2018 | -13,365.00 |
| Jun 30, 2018 | -16,335.00 |
| Mar 31, 2018 | -25,760.00 |
| Dec 31, 2017 | -6.13 Mn |
| Sep 30, 2017 | 399,776.00 |